Yukihiro Imai

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study

Shunsuke Teraoka, Daichi Fujimoto, Takeshi Morimoto et al. · Journal of Thoracic Oncology · 2017 · 377 citations · Full text

Medicine, Immunology, Oncology +14

Rebiopsy of non–small cell lung cancer patients with acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor

Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka et al. · Cancer · 2013 · 178 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Clinical Features and Outcome of Acute Exacerbation of Interstitial Pneumonia: Collagen Vascular Diseases-Related versus Idiopathic

Ryo Tachikawa, Keisuke Tomii, Hiroyuki Ueda et al. · Respiration · 2011 · 156 citations · Full text

Medicine, Internal Medicine, Inflammation +9

Spatiotemporal T790M Heterogeneity in Individual Patients with EGFR-Mutant Non–Small-Cell Lung Cancer after Acquired Resistance to EGFR-TKI

Akito Hata, Nobuyuki Katakami, Hiroshige Yoshioka et al. · Journal of Thoracic Oncology · 2015 · 156 citations · Full text

Medicine, Genetics, Oncology +16

Complex Mutations in the Epidermal Growth Factor Receptor Gene in Non-small Cell Lung Cancer

Akito Hata, Hiroshige Yoshioka, Shiro Fujita et al. · Journal of Thoracic Oncology · 2010 · 97 citations

Medicine, Genetics, Oncology +12